This brand name is authorized in Japan
The drug ACONIP contains one active pharmaceutical ingredient (API):
UNII XXE1CET956 - INDOMETHACIN
Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
|M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
This drug has been assigned below unique identifiers within the countries it is being marketed:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.